News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement
|Articles|April 10, 2009

Woty-Podcast-Kathy Giusti

Advertisement

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement

Related Content

Advertisement
Pharmaceutical Executive Daily

Pharmaceutical Executive Daily: Analysis on TrumpRx List Pricing

ByNicholas Jacobus
March 19th 2026
Stock.adobe.com

TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report

ByNicholas Jacobus
March 19th 2026
Stock.adobe.com

What Does Infinitus Think About the Relationship Between AI Automation and Human Oversight?

ByNicholas Jacobus,Ankit Jain
March 19th 2026
Stock.adobe.com

What Does a Truly Ai-Native Patient Access Infrastructure Look Like in 2026?

ByNicholas Jacobus,Ankit Jain
March 19th 2026
Matthew Turner

How Paysign Assists Manufacturers Making the Connection from Copay Program Investment to Downstream Adherence

ByNicholas Jacobus,Matthew Turner
March 19th 2026
Advertisement
Advertisement

Trending on PharmExec

1

What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them

2

FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents

3

What Governance Resets Should Pharma Companies Take in Response to AI?

4

Conflict in Middle East Disrupts Pharma Drug Supplies: Report

5

TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us